Pravastatin was not better than usual care in reducing all-cause mortality or CHD events

Affiliations

Comment

Arthur T Evans et al. ACP J Club. 2003 Jul-Aug.

. 2003 Jul-Aug;139(1):10.

No abstract available

Comment on

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002 Dec 18;288(23):2998-3007. doi: 10.1001/jama.288.23.2998. JAMA. 2002. PMID: 12479764 Clinical Trial.